Ozempic, a popular weight-loss and diabetes drug, is facing a substantial $2 billion lawsuit consolidating claims from approximately 1,800 users. The lawsuit alleges severe vision loss and raises new concerns about a potential link to aggressive thyroid cancer.

• The lawsuit seeks over $2 billion in damages, combining claims from roughly 1,800 users.
• Plaintiffs report suffering sudden blindness due to conditions like non-arteritic anterior ischemic optic neuropathy (NAION) and new fears regarding aggressive thyroid cancer.
• The drug's manufacturer maintains Ozempic is safe when used as prescribed, with benefits outweighing risks, while critics call for greater caution and transparent safety studies.